Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE‐1, EVOLVE‐2, and REGAIN Randomized, Double‐Blind, Placebo‐Controlled Studies

OBJECTIVE: To examine the likelihood of response with continued galcanezumab treatment in patients with episodic or chronic migraine without initial clinical improvement. BACKGROUND: A percentage of patients with migraine may require additional time on pharmacotherapy but discontinue treatment prema...

Descripción completa

Detalles Bibliográficos
Autores principales: Nichols, Russell, Doty, Erin, Sacco, Sara, Ruff, Dustin, Pearlman, Eric, Aurora, Sheena K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587751/
https://www.ncbi.nlm.nih.gov/pubmed/30462830
http://dx.doi.org/10.1111/head.13443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587751/
https://www.ncbi.nlm.nih.gov/pubmed/30462830
http://dx.doi.org/10.1111/head.13443

Ejemplares similares